Diabetes
The main symptoms that allow to suspect diabetes include unmotivated weakness, thirst, excessive urination, burning and discomfort in the feet, reduced vision, weight gain (type 2 diabetes) or loss (type 1), interruptions in sexual function.
Diagnosis of diabetes mellitus is based on studies of fasting sugar, sugar load in the blood and urine, and on the study of “hidden sugar” (glycosylated hemoglobin) in the blood. Sugar on an empty stomach is more than 7.0 (126), and 2 hours after a load of more than 10 (180), as well as glycosylated hemoglobin more than 7.0, allow you to establish the diagnosis of diabetes with 100% accuracy. Accordingly, fasting sugar 6 (108) – 8 (144), after a load of less than 7.5, and glycosylated hemoglobin 6.3 – 7.0, suggest prediabetes and impaired carbohydrate tolerance. A single measurement of blood glucose is not a basis for diagnosis.
Treatment of diabetes in our clinic includes the classical, regenerative (cell therapy) and monitoring stages. At the 1st stage, the level of sugars is corrected and the fight against the developed complications by the methods of medicinal and physiotherapy, with the participation of an endocrinologist, a neurologist, and if necessary, a nephrologist, a urologist, a cardiologist, a rehabilitologist, orthopedist. The main focus is on the compensation of sugar (no more than 10 or 180 2 hours after eating and monitoring complications from nerves, kidneys, heart, reproductive system), which allows you to prepare the body for the main stage – the introduction of stem cells. Pluripotent (multifunctional) stem cells from the embryo’s liver are used to ensure the formation of new healthy vessels and increase the insulin reserve in the pancreas, placental cells that play the role of an immunity adjuster and special stem cells from the buds of various organs: brain, soft tissues, spleen, heart, kidney etc. The dose and type of special cells are selected individually, depending on the actual complications and symptoms. The first 2 stages take 5 days, after which the patient receives home recommendations for the monitoring phase. This stage lasts from 3 to 6 months, is carried out distantly and includes periodic monitoring of sugar diaries, control of glycosylated hemoglobin and C-peptide (insulin reserve dynamics), control of albumin (special proteins) in the urine and recommendations.
The prognosis for type 1 diabetes: reducing the dose of insulin and the multiplicity of injections by 1.5–3 times, preventing ocular, renal, and cardiovascular complications; if the recommendations are followed, remission can last from 1 to 5 years;
With type 2 diabetes, it is possible to reduce the number of pills, avoid insulin, stop pain symptoms, normalize pressure, restore sexual function, and lose weight. The effect can also last up to 5 years or more.
